Tuberculosis patients’ satisfaction with directly observed treatment short course strategy and associated factors in Southern Ethiopia: a mixed method study.

Tuberculosis patients’ satisfaction with directly observed treatment short course strategy and associated factors in Southern Ethiopia: a mixed method study.

Publication date: Sep 09, 2024

Tuberculosis (TB) is a second major global public health problem and the leading infectious cause of death in Ethiopia. Patients under directly observed treatment short-courses (DOTs) have a higher treatment success rate and reduced drug resistance. A successful treatment outcome and adherence to the treatment are related to patient satisfaction with the DOT strategy. Client satisfaction is one of the indicators of the quality of care. In this perspective, there were limited studies in Ethiopia related to patient satisfaction with the DOTs strategy in the prevention and control of TB to achieve the ”END TB Strategy. ” Therefore, this study was aimed at identifying the TB patients’ satisfaction with the DOTs strategy and associated factors in Gamo Zone, Southern Ethiopia. An institutional-based cross-sectional study design for quantitative data and a phenomenological approach were employed for qualitative data. The calculated sample size was 374. A systematic random sampling method was used to select study participants. A pre-tested structured interviewer-administered questionnaire for quantitative data and focus group discussions (FGDs) for qualitative data were used for data collection. Bivariable and multivariable analyses were used. The determinants with a p-value 

Open Access PDF

Concepts Keywords
Ethiopia Ethiopia
Interviewer Patient satisfaction
Qualitative Tuberculosis
Success
Tuberculosis

Semantics

Type Source Name
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease MESH cause of death
drug DRUGBANK Spinosad
disease IDO quality
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH death
drug DRUGBANK Water
disease MESH COVID 19
disease MESH AIDS
drug DRUGBANK Trestolone
drug DRUGBANK Indoleacetic acid
disease IDO facility
disease IDO process
disease MESH privacy
disease IDO symptom
drug DRUGBANK Serine
drug DRUGBANK Ranitidine
disease MESH TB meningitis
disease MESH peritonitis
disease MESH pericarditis
disease MESH concomitant disease
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH psychological well being
disease MESH Marital status
disease MESH Educational status
drug DRUGBANK Esomeprazole
drug DRUGBANK Etoperidone
disease IDO country
drug DRUGBANK Vorinostat

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *